News
1 in 3 adults in the U.S. and Europe take at least one supplement a day. While they can support better health, taking too ...
15don MSN
Merck released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA ...
BRIDGEWATER, N.J. and BENGALURU, India, April 10, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the ...
10h
News-Medical.Net on MSNUVA researcher wins major grant to revolutionize breast cancer treatmentA promising approach to achieve safer, more effective, and more precise breast cancer treatment has earned a University of ...
Ninety-two percent of patients had 28 fractions of radiation with median dosage of 50.4 Gy and duration of 39 days, and 91% of the patients in CRT arm received at least 4 cycles of weekly ...
He told Parade that he completed his sixth round of chemotherapy in February and received encouraging results from the biopsy on his lymph node. “Melissa and I waited for a week to get the ...
Dick Wexelblat tells us what it was like to work in the building that now houses the fictional Lumon Industries in "Severance ...
Deoxyribose is already a naturally occurring sugar in the body, and the gel developed by the research team is biodegradable ...
She was healthy, young, active and had no risk factors for colorectal cancer, but there were warning signs. "It can happen to ...
Shares of Charles River Labs (CRL) crashed 28% after the U.S. FDA (Food and Drug Administration) announced plans to phase out the need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results